/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749876632&Signature=NtQT6W~nRCS4lQO6bo0ybz-wt5K-NNleGEujvNOy0vvMfC0BZWs23Ge-3Z9wQVNvqFXXzsETHaZ7F83BhAhcL6VNTYPIYCVSfugtPoxOT93BPYuOWVsKr~QHScC1bmmzWjK9WEaQ~18YA5MwfozKGnA6MXf4KqpF9JwR1X20KifhCMtVNGdbsf8rO0VmupG3P2VUxyCQUr7xD8uBmgDFZWJhX2rnr4pHFrNR9nh~V~WwIvNs9M~Twq~Za4mHbHrYRjV8d8nDvZd-k2~lKGKUnvnVYYKAxL66LO7At3XQjEyafBB09DTm~0GpPzu3OTolFz3m62arIgSKnM2pnu6h~w__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Galapagos NV | Belgium | GLPG | |
|
GEIGER COUNTER LIMITED | Jersey | GCL | |
|
Geneuro | Switzerland | GEM | |
|
GENFIT | France | GNFT | |
|
GENFLOW BIOSCIENCES PLC | United Kingdom | GENF | |
|
Genmab | Denmark | GMAB | |
|
Genomic Vision | France | GV | |
|
Genovis AB | Sweden | GENO | |
|
genOway | France | ALGEN | |
|
GenSight Biologics S.A. | France | SIGHT |